Ra Medical Systems, Inc.

Ra Medical Systems, Inc.

RMED
Ra Medical Systems, Inc.US flagNew York Stock Exchange Arca
0.59
USD
+0.05
- -
3.84MMarket Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChatGPT
CEO
David A. Jenkins
Full Time Employees
14
Sector
Healthcare
Industry
Medical - Devices
Address
2070 Las Palmas Drive Carlsbad CA United States of America 92011
IPO Date
Sep 27, 2018
Website
ramed.com
Business
Ra Medical Systems, Inc. (RMED) develops, manufactures and commercializes innovative medical devices for the non-invasive treatment of vascular conditions. The company offers core products including the Pharos Excimer Laser System and the Nano-Clad catheter platform for excimer laser atherectomy; the B-Laser and B-Cath for below-the-knee indications; and disposable catheter products such as the Turbo S510 and Turbo Elite, designed for the treatment of peripheral artery disease (PAD), in-stent restenosis, and other vascular interventions. Ra Medical operates primarily in the United States, targeting vascular specialists, hospitals, and outpatient clinics, with headquarters in Carlsbad, California, where it was founded in 2002. In recent developments within the last two years, the company has focused on strategic operational enhancements, including the launch of next-generation excimer laser technology and expanded indications for its catheter systems to address complex PAD cases; additionally, it completed a significant reverse stock split and delisting preparations from Nasdaq amid financial restructuring efforts to streamline operations and pursue growth in the vascular device market.

Company News

APIChatGPT
  • Reminder: Ra Medical Systems Announces Name and Ticker Symbol Changes

  • Ra Medical Systems Announces Allowance of New Closure Device Patent

  • Ra Medical Systems Announces Milestone Achievement for Electrophysiology Division

  • Ra Medical Systems Announces Proposed Name and Ticker Symbol Changes

  • Ra Medical Systems Announces Date of Special Shareholder Meeting

  • Why Is Ra Medical (RMED) Stock Up 25% Today?

  • SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger - IRBT, CYBE, TRQ, HIL, RMED

  • Why These ‘Must Watch' Penny Stocks Are Climbing Right Now

  • Why Was Ra Medical Systems (RMED) Stock Up 20% Today?

  • Why Is Ra Medical Systems (RMED) Stock Up 30% Today?

  • Ra Medical Systems Enters Into Definitive Merger Agreement with Catheter Precision

  • Penny Stocks To Watch: Why KRKR, RMED, TYME, TTNP & ENDP Stock Are Moving

  • Why Ra Medical Systems Shares Are Trading Higher Today?

  • Ra Medical Systems, Inc. (RMED) CEO Will McGuire on Q1 2022 Results - Earnings Call Transcript

  • Ra Medical Systems Reports First Quarter 2022 Financial Results

  • Ra Medical Systems to Report First Quarter 2022 Financial Results on May 16, 2022

  • Ra Medical Systems, Inc. (RMED) CEO Will McGuire on Q4 2021 Results - Earnings Call Transcript

  • Ra Medical Systems Reports 2021 Fourth Quarter and Full Year Financial Results

  • Best Penny Stocks To Buy? 4 Biotech Stocks To Watch Right Now

  • 5 Penny Stocks Under $1 To Buy According To Redditors This Week